Ezetimibe AAH-IN-2 providing a therapeutic strategy for

providing a therapeutic strategy for improving the efficacy of granulocyte transfusion

CAS Number: 141400-58-0

B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway

1401966-69-5 (free base)

Serrano-Mollar A

Ezetimibe AAH-IN-2 providing a therapeutic strategy forEzetimibe, also known as SCH 58235, is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone when other cholesterol lowering medications are not tolerated, or together with statins (e. g., ezetimibe simvastatin) when statins alone do not control cholesterol. Ezetimibe is recommended as second line therapy for those intolerant of statins or unable to achieve target LDL